CVS HEALTH Corp Long-Term Concentrated

CIK: 0000064803 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 12, 2022

Total Value ($000): $120,603 (100.0% shares, 0.0% debt)

Holdings (6)

HDV ISHARES CORE HIGH DIVIDEND ETF 52.0%

Value ($000) $62,722 Shares 624,536 Est. Cost $100.99 Unrealized —

VYM VANGUARD WHITEHALL FDS 17.9%

Value ($000) $21,645 Shares 212,832 Est. Cost $112.25 Unrealized —

SCHD SCHWAB STRATEGIC TR US DIV 17.6%

Value ($000) $21,275 Shares 297,006 Est. Cost $78.89 Unrealized —

— LUMIRADX LTD 11.8%

Value ($000) $14,237 Shares 5,352,106 Est. Cost $8.91 Unrealized —

HCAT HEALTH CATALYST INC 0.4%

Value ($000) $467 Shares 32,273 Est. Cost $45.57 Unrealized -62.6%

PRU PRUDENTIAL FINANCIAL INC 0.2%

Value ($000) $257 Shares 2,683 Est. Cost $88.87 Unrealized -0.4%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
HDV	ISHARES CORE HIGH DIVIDEND ETF	624,536	$62,722	52.0%	$100.99	—	COM	46429B663
VYM	VANGUARD WHITEHALL FDS	212,832	$21,645	17.9%	$112.25	—	COM	921946406
SCHD	SCHWAB STRATEGIC TR US DIV	297,006	$21,275	17.6%	$78.89	—	COM	808524797
—	LUMIRADX LTD	5,352,106	$14,237	11.8%	$8.91	—	COM	G5709L117
HCAT	HEALTH CATALYST INC	32,273	$467	0.4%	$45.57	-62.6%	COM	42225T107
PRU	PRUDENTIAL FINANCIAL INC	2,683	$257	0.2%	$88.87	-0.4%	COM	744320102